non-small cell lung cancer with EGFR gene mutation
Conditions
Interventions
None listed
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Cases of non-small cell lung cancer that have been proven histologically or cytologically and are subject to medical treatment. (2) Mutations are recognized in approved companion diagnostics using tumor tissue or cells. (3) Age is 20 years or older.
Exclusion criteria
Exclusion criteria: Those deemed inappropriate for participation in this research by the principal investigator or research collaborators.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| NLR (Neutrophil-to-Lymphocyte Ratio) | — |
Secondary
| Measure | Time frame |
|---|---|
| Site of occurrence, maximum tumor diameter, site of metastasis, type of genetic mutation, treatment details after secondary treatment and whether ICI or EGFR-TKI was used, PLR(Platelet-to-Lymphocyte Ratio), GPS(Glasgow Prognostic Score), PNI(Prognostic Nutritional Index), etc. | — |
Countries
Japan
Contacts
Shinshu University School of Medicine First Department of Internal Medicine